Longitudinal evaluation of serovar-specific immunity to Neisseria gonorrhoeae

American Journal of Epidemiology

Volumn 149, Issue 4, 1999, Pages 353-358

  Fox, Kimberley K ^a   Thomas, James C ^a,b   Weiner, Debra H ^c   Davis, Rachael H ^a,d   Frederick Sparling, P ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c IL   (United States)

^d FAMILY HEALTH INTERNATIONAL   (United States)

Author keywords

Epidemiology, molecular; Gonorrhea; Immunity, natural; Neisseria gonorrhoeae; Serotyping; Sexually transmitted diseases, bacterial

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; FEMALE; GONORRHEA; HUMAN; MAJOR CLINICAL STUDY; MALE; NEISSERIA GONORRHOEAE; REINFECTION; SEROTYPING; SEXUALLY TRANSMITTED DISEASE;

EID: 0033557778     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009820     Document Type: Article

References (28)

1. McCormack WM. Pelvic inflammatory disease. N Engl J Med 1994;330:115-19.
2. Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet 1997;349: 1868-73.
3. Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993;7:95-102.
4. Elkins C, Sparling PR Immunobiology of Neisseria gonorrhoeae. In: Quinn TC, ed. Sexually transmitted diseases. New York, NY: Raven Press, 1992:113-39.
5. Johnston KH, Holmes KK, Gotschlich EC. The serological classification of Neisseria gonorrhoeae. I. Isolation of the outer membrane complex responsible for serotypic specificity. JExpMedl976;143:741-58.
6. Knapp JS, Tarn MR, Nowinski RC, et al. Serological classification of Neisseria gonorrhoeae with use of monoclonal antibodies to gonococcal outer membrane protein I. J Infect Dis 1984;150:44-8.
7. Tarn MR, Buchanan TM, Sandstrom EG, et al. Serological classification of Neisseria gonorrhoeae with monoclonal antibodies. Infect Immun 1982;36:1042-53.
8. Kohl PK, Ison CA, Danielsson D, et al. Current status of serotyping of Neisseria gonorrhoeae. EUT J Epidemiol 1990; 6:91-5.
9. Sarafian SK, Knapp JS. Molecular epidemiology of gonorrhea. Clin Microbiol Rev 1989;2(suppl):S49-55.
10. Knapp JS, Holmes KK, Bonin P, et al. Epidemiology of gonorrhea: distribution and temporal changes in auxotype/serovar classes of Neisseria gonorrhoeae. Sex Transm Dis 1987; 14:26-32.
11. Young H, Moyes A, Ross J, et al. A serovar analysis of heterosexual gonorrhoea in Edinburgh 1986-90. Genitourin Med 1992;68:16-19.
12. Plummer FA, Simonsen JN, Chubb H, et al. Epidemiologie evidence for the development of serovar-specific immunity after gonococcal infection. J Clin Invest 1989;83:1472-6.
13. Kohl PK, Elkins C, Kratofiel M, et al. Detection of antibodies against gonococcal porin peptides in cervical secretions from prostitutes. In: Proceedings of the Tenth International Meeting of the International Society for STD Research, Helsinki, Finland, August 1993. (Abstract 42).
14. Lammel CJ, Sweet RL, Rice PA, et al. Antibody-antigen specificity in the immune response to infection with Neisseria gonorrhoeae. ] Infect Dis 1985;152:990-1001.
15. Zak K, Diaz J-L, Jackson D, et al. Antigenic variation during infection with Neisseria gonorrhoeae: detection of antibodies to surface proteins in sera of patients with gonorrhea. J Infect Dis 1984;149:166-74.
16. Elkins C, Carbonetti NH, Varela VA, et al. Antibodies to Nterminal peptides of gonococcal porin are bactericidal when gonococcal lipopolysaccharide is not sialylated. Mol Microbiol 1992;6:2617-28.
17. Virji M, Fletcher JN, Zak K, et al. The potential protective effect of monoclonal antibodies to gonococcal outer membrane protein IA. J Gen Microbiol 1987;133:2639-46.
18. Virji M, Zak K, Heckels JE. Monoclonal antibodies to gonococcal outer membrane protein IB: use in investigation of the potential protective effect of antibodies directed against con-served and type-specific epitopes. J Gen Microbiol 1986;132: 1621-9.
19. Thomas JC, Schoenbach VJ, Weiner DH, et al. Rural gonorrhea in the southeastern United States: a neglected epidemic? Am J Epidemiol 1996; 143:269-77.
20. Abdillahi H, Poolman JT. Whole-cell ELISA for typing Neisseria ineningitidis with monoclonal antibodies. FEMS Microbiol Lett 1988;47:367-71.
21. Cohen MS, Heine RP. Mucosal defenses and microbial pathogens of the genital tract. In: Quinn TC, ed. Sexually transmitted diseases. New York, NY: Raven Press, 1992: 39-55.
22. Schoenbach VJ, Landis SE, Weber DJ, et al. HIV seroprevalence in sexually transmitted disease clients in a low-prevalence southern state: evidence of endemic sexual transmission. Ann Epidemiol 1993;3:281-8.
23. Ross JD, Moyes A, Young H. Serovar specific immunity to Neisseria gonorrhoeae: does it exist? Genitourin Med 1995; 71:367-9.
24. 2-generation. J Biol Chem 1988;263:945-51.
25. Arminjon P, Cadoz M, Morse SA, et al. Bactericidal and opsonic activities of sera from individuals immunized with a gonococcal protein I vaccine. In: Proceedings of the Annual Meeting of the American Society for Microbiology. Atlanta, GA: American Society for Microbiology, 1987. (Abstract E-92).
26. Rice PA, Vayo HE, Tarn MR, et al. Immunoglobulin G antibodies directed against protein III block killing of serumresistant Neisseria gonorrhoeae by immune serum. J Exp Med 1986;164:1735-48.
27. Tai Y, Michon F, Fusco PC, et al. Preclinical evaluation of a combination vaccine against groups A, B and C meningococci in both mice and nonhuman primates. In: Zollinger \VD, Frasch CE, Deal CD, eds. Abstracts of the Tenth International Pathogenic Neisseria Conference, Baltimore, Maryland, September 1996:214-15.
28. Cohen MS, Cannon JG, Jerse AE, et al. Human experimentation with Neisseria gonorrhoeae: rationale, methods, and implications for the biology of infection and vaccine development. J Infect Dis 1994;169:532-7.